Clinical Trials in San Antonio

Showing 2801-2820 of 12,572 trials

Post-approval Study of New Enrolment Patients Undergoing Bilateral Treatment With the VisuMax SMILE Procedure

NCT05740293

The objective of the post-approval study (PAS) is to assess patient experience of visual symptoms 6 months after bilateral treatment with the VisuMax SMILE procedure as measured by a patient questionnaire.

MyopiaAstigmatism

Carl Zeiss Meditec, Inc.186 participantsStarted Apr 2022

Fayetteville, Arkansas, United States • Rowland Heights, California, United States • Leawood, Kansas, United States +4 more locations

Active Not RecruitingPhase 3< 1 mile

A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

NCT04437511

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease. Additional participants will be enrolled to an addendum safety cohort. The participants will be administered open-label donanemab. Trial participants who were dosed with donanemab in the main study will be enrolled to a 3-year follow up addendum. No study drug will be administered during this follow up.

Alzheimer Disease

Eli Lilly and Company1,736 participantsStarted Jun 2020

Gilbert, Arizona, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +271 more locations

Post-approval Study of New Enrolment Patients Undergoing Bilateral Treatment With the VisuMax SMILE Procedure

A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

Find Trials by Condition in San Antonio

Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma

A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies

Telehealth 2.0: Evaluating Effectiveness and Engagement Strategies for CPT-Text for PTSD

Clinical Effect, Safety and Tolerability of GSK1070806 in Atopic Dermatitis

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRα) Expression

A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome

Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866)

Tucatinib, Trastuzumab, and Capecitabine for the Treatment of HER2+ LMD

Treatment of GVHD in Hematopoietic Stem Cell Transplant (HSCT) Recipients Using AAT Plus Corticosteroids (CS) Compared With Corticosteroids Alone

Study of PF-07265807 in Participants With Metastatic Solid Tumors.

Vivaer® Procedure for Treatment of Nasal Airway Obstruction Study

Mitral Valve Screening Survey

Long-Term Evaluation of BIIB067 (Tofersen)

A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction

A Study Investigating DNA-damage Response Agents in Molecularly Altered Advanced Cancer

A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis

An Extension Study of JR-171-101 Study in Patients With Mucopolysaccharidosis Type I (MPS I)